Loading…
Pharvaris N.V. is projected to rise to $41.45 by 2027, a +41% move from its current price of $29.47. PHVS is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $28.70 | $29.49 | $30.30 | +0.07% |
| May 30 | $28.40 | $29.51 | $30.67 | +0.14% |
| May 31 | $28.17 | $29.53 | $30.96 | +0.21% |
| Jun 1 | $27.98 | $29.55 | $31.20 | +0.27% |
| Jun 2 | $27.82 | $29.57 | $31.43 | +0.34% |
| Jun 3 | $27.68 | $29.59 | $31.63 | +0.41% |
| Jun 4 | $27.55 | $29.61 | $31.82 | +0.48% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $27.55 | $29.61 | $31.82 | +0.48% |
| Week 2 | $26.87 | $29.75 | $32.94 | +0.96% |
| Week 3 | $26.39 | $29.90 | $33.87 | +1.45% |
| Week 4 | $26.01 | $30.04 | $34.70 | +1.93% |
| Week 5 | $25.69 | $30.18 | $35.46 | +2.42% |
| Week 6 | $25.42 | $30.33 | $36.18 | +2.91% |
| Week 7 | $25.18 | $30.47 | $36.87 | +3.41% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Pharvaris N.V. is a late-stage biopharmaceutical company focused on the development and commercialization of therapies for rare diseases with unmet needs covering angioedema and other bradykinin-mediated diseases. The company develops deucrictibant, a small molecule bradykinin B2-receptor antagonist to treat attacks due to bradykinin-mediated angioedema, including hereditary angioedema (HAE) and acquired angioedema due to C1-inhibitor deficiency (AAE-C1INH), which is in phase 3, as well as in phase 3 trials for treatment and prophylaxis of HAE attacks; and extended-release tablet and immediate-release capsule formulation of deucrictibant.
Pharvaris N.V. was incorporated in 2015 and is headquartered in Zug, Switzerland.
PHVS is Pharvaris N.V., a healthcare stock with a current price of $29.68 and a market cap of $2.07B. It is ranked 1977.
The near-term price outlook is anchored by the 30-day forecast spectrum, with 2026 showing min $24.05, avg $29.68, max $38.85 and a NEUTRAL sentiment.
From 2027 onward, the forecast portrays a bullish trajectory, with rising averages and higher max values through 2035 and beyond. For example, 2027 avg is $42.19, 2030 avg is $62.22, and 2050 avg is $321.85, with the 2050 max reaching $607.50.
Overall, the multi-year forecast indicates meaningful upside potential over the long term.
A major floor 17.7% below — a decisive break under it would weaken the trend.
The nearest floor, 7.4% below — buyers have tended to step in here.
The nearest ceiling, 11.8% above — a clean break opens room to run.
A major ceiling 20.6% above — clearing it would confirm fresh momentum.
Key PHVS support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of PHVS market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $29.80 | Sell | $29.73 | Sell |
| MA 10 | $30.08 | Sell | $29.85 | Sell |
| MA 20 | $30.11 | Sell | $29.76 | Sell |
| MA 50 | $28.69 | Buy | $28.95 | Buy |
| MA 100 | $27.71 | Buy | $27.78 | Buy |
| MA 200 | $25.75 | Buy | $25.83 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 49.42 | Neutral |
| Stoch RSI (14) | 12.29 | Buy |
| CCI (20) | -69.22 | Neutral |
| Williams %R (14) | -84.02 | Info |
| MACD (12,26,9) | -0.18 | Sell |
| ROC (12) | -2.06 | Sell |
| Bollinger %B (20,2) | 0.32 | Neutral |
| Stochastic %K (14) | 15.98 | Buy |
| TRIX (15) | 0.23 | Buy |
| Awesome (5,34) | 0.39 | Buy |
| Ultimate (7,14,28) | 43.86 | Neutral |
| Momentum (10) | -1.78 | Sell |
| Aroon Osc (25) | 56.00 | Buy |
| Hull MA (9) | 29.84 | Sell |
| ADX (14) | 9.88 | Neutral |
| ATR (14) | 0.75 | Info |
The 30-day technical picture is bullish. RSI14 sits at 50, and near-term momentum is supported by a price backdrop that favors upside. The 50-day simple moving average (SMA50) is $28.55, while the 200-day simple moving average (SMA200) is $25.66.
Support is identified at $27.29, with resistance at $32.94. The 30-day range spans from $24.55 to $35.88, illustrating considerable near-term volatility but a bias toward higher prices.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $24.05 | $29.47 | $38.53 | 0% | Neutral | |
| $32.88 | $41.45 | $55.35 | +41% | Bullish | |
| $38.60 | $49.98 | $69.16 | +70% | Bullish | |
| $41.66 | $55.19 | $78.54 | +87% | Bullish | |
| $45.52 | $61.53 | $89.69 | +109% | Bullish | |
| $47.66 | $65.61 | $97.65 | +123% | Bullish | |
| $51.00 | $71.42 | $108.30 | +142% | Bullish | |
| $54.44 | $77.48 | $119.51 | +163% | Bullish | |
| $64.67 | $93.46 | $146.44 | +217% | Bullish | |
| $76.82 | $112.66 | $179.11 | +282% | Bullish | |
| $99.50 | $155.95 | $263.59 | +429% | Bullish | |
| $185.21 | $325.56 | $601.73 | +10.0x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $24.05 | $29.47 | $34.66 | +0.00% |
| June 2026 | $26.05 | $30.60 | $36.78 | +3.82% |
| July 2026 | $26.49 | $31.37 | $38.22 | +2.52% |
| August 2026 | $25.63 | $30.56 | $37.62 | -2.58% |
| September 2026 | $25.19 | $30.19 | $37.48 | -1.19% |
| October 2026 | $25.72 | $30.98 | $38.76 | +2.62% |
| November 2026 | $25.59 | $30.96 | $38.99 | -0.07% |
| December 2026 | $25.03 | $30.41 | $38.53 | -1.78% |
Click any year to see its month-by-month PHVS forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, PHVS is projected to trade between $24.05 and $38.53, averaging $29.47 — a potential gain of 0% from today's $29.47. Price action looks broadly range-bound.
Pharvaris N.V.'s 2027 outlook centres on $41.45, within a $32.88 to $55.35 range. That is up +41% on the projected 2026 average. That marks a +41% change versus current levels. Buyers look set to stay in control over this stretch.
By 2028, PHVS could reach as high as $69.16, with a base case around $49.98 and support toward $38.60 — roughly +70% from $29.47. Momentum favours further upside here.
Expect PHVS to range from $41.66 to $78.54 through 2029. The $55.19 average target implies a +87% move from current prices. That is up +10% on the projected 2028 average. Buyers look set to stay in control over this stretch.
The PHVS price prediction for 2030 points to an average of $61.53 (low $45.52, high $89.69) — a potential gain of +109% on today's $29.47. Momentum favours further upside here.
In 2031, PHVS is projected to trade between $47.66 and $97.65, averaging $65.61 — a potential gain of +123% from today's $29.47. That is up +7% on the projected 2030 average. Buyers look set to stay in control over this stretch.
Pharvaris N.V.'s 2032 outlook centres on $71.42, within a $51.00 to $108.30 range. That is up +9% on the projected 2031 average. That marks a +142% change versus current levels. Momentum favours further upside here.
By 2033, PHVS could reach as high as $119.51, with a base case around $77.48 and support toward $54.44 — roughly +163% from $29.47. Buyers look set to stay in control over this stretch.
Expect PHVS to range from $64.67 to $146.44 through 2034. The $93.46 average target implies a +217% move from current prices. That is up +21% on the projected 2033 average. Momentum favours further upside here.
The PHVS price prediction for 2035 points to an average of $112.66 (low $76.82, high $179.11) — a potential gain of +282% on today's $29.47. Buyers look set to stay in control over this stretch.
In 2040, PHVS is projected to trade between $99.50 and $263.59, averaging $155.95 — a potential gain of +429% from today's $29.47. That is up +38% on the projected 2035 average. Momentum favours further upside here.
Pharvaris N.V.'s 2050 outlook centres on $325.56, within a $185.21 to $601.73 range. That is up +109% on the projected 2040 average. That marks a +10.0x change versus current levels. Buyers look set to stay in control over this stretch.
Investing $1,000 in PHVS today (≈ 33.932813 PHVS) could be worth
$11,047.26
+$10,047.26 (+1005%) by 2050 · US Dollar
Based on the average projected PHVS price of $325.56 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in PHVSwould be worth at today's price.
$1,000 invested in PHVS on May 27, 2025 (≈ 63.131313 PHVS) would be worth
$1,860.48
+$860.48 (+86.0%) today · 1.86× · US Dollar
Based on a PHVS entry price of $15.84 vs. today's $29.47.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $29.45 | $1,000.68 | +0.1% |
| 1 month ago | $28.71 | $1,026.47 | +2.6% |
| 3 months ago | $28 | $1,052.5 | +5.2% |
| 6 months ago | $28.38 | $1,038.41 | +3.8% |
| 1 year ago | $15.84 | $1,860.48 | +86.0% |
| All time (5.0y) ago | $20.65 | $1,427.12 | +42.7% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our PHVS forecast.
Our base-case forecast reaches $59.00 around 2030.
Implied market cap at $59.00: $4.12B
The multi-year forecast shows bullish sentiment across the long horizon. In 2030, the average forecast price is $62.22 with a min of $45.56 and a max of $91.77, and an ROI of 109.6. The sentiment for 2030 is BULLISH.
By 2040, the forecasted average rises to $153.39 with an ROI of 416.8. By 2050, the average is projected at $321.85 with an ROI of 984.4, remaining bullish in outlook. These figures imply substantial upside potential through mid-century and beyond, while noting that these are estimates and not guarantees.
Tap a question to reveal the answer.
2030 min $45.56, avg $62.22, max $91.77, ROI 109.6, sentiment BULLISH.
Forecasts show bullish sentiment from 2027 onward, with rising averages: 2027 avg $42.19, 2050 avg $321.85, and ROI up to 984.4.
Yes. The forecast shows max values above $100 in multiple years: 2032 $108.97; 2033 $121.07; 2034 $147.59; 2035 $182.13; 2040 $263.92; 2050 $607.50.
Current price $29.68; thirty-day range $24.55-$35.88.
2030 avg $62.22 ROI 109.6; 2040 avg $153.39 ROI 416.8; 2050 avg $321.85 ROI 984.4; sentiment BULLISH.
Pharvaris N.V. Community Discussion
0Share your Pharvaris N.V. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.